MMRN-2, is expressed during embryonic development and can also interfere with tumour angiogenesis and growth.
| Inventor | Institute |
|---|---|
| Alfonso Colombatti ; Paola Spessotto ; Roberto Doliana ; Maria Teresa Mucignat | National Cancer Institute CRO – Aviano |
| SKU: | 160585 |
|---|---|
| Product description: | Multimerin-2 (MMRN-2), also known as Emilin-3 (Elastin Microfibril Interface Located proteIN), is an extracellular matrix glycoprotein. Is part of a protein family which have been shown to be expressed in smooth muscle and other mesenchymal tissues and is localized at the proximity of elastin and microfibrils. MMRN-2, is expressed during embryonic development and can also interfere with tumour angiogenesis and growth. |
| Alternate name: | Emilin-3 (Elastin Microfibril Interface Located proteIN) |
| Conjugation: | Unconjugated |
| Isotype: | Not Known |
| Immunogen: | Recombinant murine MMRN-2 as immunizing antigen; Wistar rat as host |
| Cat. #: | 160585 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Developmental biology |
| Application: | IHC ; IF ; WB |
| Target: | mMMRN2 |
| Reactivity: | Mouse |
| Host: | Rat |
| Class: | Monoclonal |
| Target background: | Multimerin-2 (MMRN-2), also known as Emilin-3 (Elastin Microfibril Interface Located proteIN), is an extracellular matrix glycoprotein. Is part of a protein family which have been shown to be expressed in smooth muscle and other mesenchymal tissues and is localized at the proximity of elastin and microfibrils. MMRN-2, is expressed during embryonic development and can also interfere with tumour angiogenesis and growth. |
|---|
| Format: | Liquid |
|---|---|
| Storage conditions: | Store at 2 – 8° C or aliquots at -20° C. Avoid repeated freeze-thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Danussi et al. 2012. Cancer Prev Res (Phila). 5(9):1131-43. PMID: 22827975. Danussi et al. 2008. Mol Cell Biol. 28(12):4026-39. PMID: 18411305. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.